Study guide
Myopic maculopathy and presumed ocular histoplasmosis
European Board of Ophthalmology Diploma EBOD
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: EBOD Examination, Applications and Regulations
EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals
2 Chapter 2: Physical Optics, Photometry and Lenses
Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid
3 Chapter 3: Instrument Optics, Aberrations and Laser Physics
Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT
4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing
Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses
5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation
Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics
6 Chapter 6: Extraocular Anatomy and Motor Physiology
Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys
7 Chapter 7: Binocular Vision and Amblyopia
Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment
8 Chapter 8: Childhood Assessment and Strabismus Testing
Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts
9 Chapter 9: Esotropia, Exotropia and Vertical Deviations
Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew
10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery
Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles
11 Chapter 11: ROP and Paediatric Ocular Disease
Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding
12 Chapter 12: Ocular Surface Anatomy and Infection
Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis
13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation
Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis
14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies
Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies
15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure
Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency
16 Chapter 16: Surface Reconstruction and Keratoplasty
Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems
17 Chapter 17: Lens Development, Cataract Assessment and Biometry
Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry
18 Chapter 18: IOL Planning and Phacoemulsification
Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques
19 Chapter 19: Cataract Anaesthesia and Surgical Complications
Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO
20 Chapter 20: Corneal and Intraocular Refractive Surgery
Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange
21 Chapter 21: Presbyopia Procedures and Surface Therapeutics
Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin
22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy
Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation
23 Chapter 23: Angle, Disc and Visual-Field Assessment
Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry
24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms
Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure
25 Chapter 25: POAG, Angle Closure and Pigmentary Disease
POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma
26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment
Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers
27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion
Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions
28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy
Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis
29 Chapter 29: Inherited Retina and Electrophysiology
Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina
30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid
AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum
31 Chapter 31: Retinal Breaks and Detachment Repair
PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling
32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma
Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment
33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation
SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation
34 Chapter 34: Infectious Uveitis and Endophthalmitis
Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment
35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy
Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison
36 Chapter 36: Papilloedema, IIH and Afferent Localisation
Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization
37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology
Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies
38 Chapter 38: Central Motor Control and Cranial Nerve Palsies
Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus
39 Chapter 39: Myasthenia and Ocular Myopathy
Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome
40 Chapter 40: Pupillary Pathways and Anisocoria
Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials
41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment
Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation
42 Chapter 42: Lid Repair and Lacrimal Drainage
Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR
43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours
Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma
44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease
Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling
45 Chapter 45: Ocular Trauma and Vascular Systemic Disease
Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease
46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology
Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects
47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations
Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal
Myopic maculopathy and presumed ocular histoplasmosis
Key Takeaways Explain This Topic AI
Pathologic myopia is defined by structural posterior disease rather than prescription alone.
Myopic CNV may have little fluid; haemorrhage at a lacquer crack still requires confirmation of activity.
Foveoschisis is a tractional problem and does not automatically benefit from anti-VEGF.
Classic POHS has scars, peripapillary atrophy and possible CNV without active vitritis; treat the active vascular complication.
Last updated: October 2026
Structural stretching and neovascular activity differ
Pathologic myopia involves posterior structural changes such as a posterior staphyloma and myopic maculopathy; a large negative spectacle prescription alone does not define every aspect of the disease. Myopic eyes can lose vision from atrophy, traction, a macular hole, retinal detachment or choroidal neovascularization (CNV). Distinguishing these mechanisms prevents an inappropriate injection for a purely mechanical problem or delayed treatment of active neovascular disease.
Measure corrected acuity and refraction, examine the peripheral retina and document the posterior contour. Optical coherence tomography (OCT) should be interpreted with awareness of curved anatomy, segmentation artifacts and thin choroid. A staphyloma is a localized outpouching with a change in curvature, not simply a synonym for any long eye. Prior photographs and OCT help separate stable atrophic change from newly active lesions.
Atrophic and neovascular myopic lesions
A tessellated fundus, diffuse or patchy chorioretinal atrophy and lacquer cracks may coexist. Lacquer cracks are breaks in the RPE–Bruch membrane–choriocapillaris complex and can be associated with haemorrhage. A haemorrhage near a lacquer crack is not automatically CNV; examine and image for an active vascular lesion. A Fuchs spot describes a pigmented scar associated with previous myopic neovascularization, not a current treatment indication by itself.
Myopic CNV often appears as a small lesion with comparatively little fluid. New metamorphopsia, central blur and a small subretinal haemorrhage warrant timely assessment. OCT may show a hyperreflective lesion, while fluorescein angiography can establish leakage when the diagnosis or activity is uncertain. OCT angiography can demonstrate a vascular network but cannot independently measure leakage or prove every detected network needs treatment.
Anti-vascular endothelial growth factor (anti-VEGF) therapy is an established treatment for active myopic CNV. Primary trials such as RADIANCE support ranibizumab-based treatment, with retreatment according to the specified protocol and activity. Do not impose the chronic AMD injection schedule on every myopic lesion. Counsel about recurrence, the need to return for new distortion and visual limits imposed by underlying atrophy even when the CNV becomes inactive.
Myopic traction maculopathy
A stretched posterior wall with persistent vitreoretinal and epiretinal traction may produce macular retinoschisis, foveal detachment or a macular hole. OCT distinguishes splitting of retinal layers from exudative cysts. Look for residual posterior hyaloid, epiretinal membrane and the relationship to staphyloma. The apparent increase in retinal thickness does not imply diabetic oedema.
Observe selected stable cases with useful vision and reliable monitoring. Progressive symptomatic traction, foveal detachment or a hole may require specialist surgery. Vitrectomy with careful management of traction and selected internal limiting membrane techniques, or a macular buckle in selected anatomy, has a different purpose from anti-VEGF. These procedures carry risks including hole formation, cataract and retinal detachment; the surgical approach should fit the pattern rather than simply the axial length.
- Myopic finding Principal mechanism Treatment direction
- Stable patchy atrophy Tissue loss Rehabilitation and surveillance
- Active CNV Neovascular growth Anti-VEGF after confirmation
- Foveoschisis Traction and posterior geometry Monitor or selected surgery
- Macular hole with detachment Break plus complex traction Vitreoretinal surgical planning
- Presumed ocular histoplasmosis syndrome
Presumed ocular histoplasmosis syndrome (POHS) classically combines punched-out chorioretinal scars, peripapillary atrophy and CNV, with absence of active vitreous inflammation. The syndrome has geographic associations with Histoplasma exposure, but an ocular photograph does not prove active systemic fungal infection. Not every person with peripheral scars has POHS; consider toxoplasmosis, multifocal choroiditis and other inflammatory or infectious lesions.
The clinically important complication is active CNV near the macula. Treat confirmed active neovascularization with an appropriate anti-VEGF strategy and monitor activity. Old scars alone do not require injection. Routine systemic antifungal therapy is not the treatment for the classic inactive-scar syndrome, and corticosteroids are not a universal substitute for treating the vascular lesion. Active inflammation or systemic infection changes the differential and requires its own work-up.
Applying the differential
A highly myopic patient develops new distortion and a tiny macular haemorrhage. Check for a small active CNV even if there is little OCT fluid. Another has slowly worsening vision with multilayer foveal splitting and no leakage: traction is the likely driver. A patient from an endemic region has peripheral punched-out scars, peripapillary atrophy and an active macular vascular lesion without vitritis: POHS is plausible, but the treatment targets CNV rather than assuming active fungal invasion.
Explain the mechanism to the patient, give clear instructions for new visual change and check the fellow eye. In a viva, naming myopia or POHS earns less than linking the observed lesion to the required investigation and treatment.
Sources: Primary anti-VEGF versus PDT study and EBO curriculum .
Sections you finish are checked off in the contents.
- Up Next
- Retinitis pigmentosa and inherited degeneration
- Chapter 29: Inherited Retina and Electrophysiology